M1408 Gmln brca bef diagnosis ca
Also known as: BRCA mutation status, hereditary breast cancer, gmln brca bef dx ca
Performance measure documenting germline BRCA1 or BRCA2 mutation status before diagnosis of breast cancer. Captures hereditary cancer risk assessment.
In Plain Language
Inherited gene mutations for breast cancer; Family history cancer genes tested
Clinical Context
Documents germline BRCA testing status in breast cancer patients to identify hereditary cancer syndromes requiring enhanced surveillance and family screening.
RVU Information
CPT M1408 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
M-codes cover quality measures and performance reporting. They are used in value-based care programs to track whether specific clinical actions were taken. Documentation must support that the measured action was performed or a valid exclusion applies.
Specialties
Frequently Asked Questions
What is CPT code M1408?
CPT M1408 (Gmln brca bef diagnosis ca) is a M Codes code. Performance measure documenting germline BRCA1 or BRCA2 mutation status before diagnosis of breast cancer. Captures hereditary cancer risk assessment.
Is M1408 covered by insurance?
M1408 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Documents germline BRCA testing status in breast cancer patients to identify hereditary cancer syndromes requiring enhanced surveillance and family screening.
When is CPT M1408 used?
Documents germline BRCA testing status in breast cancer patients to identify hereditary cancer syndromes requiring enhanced surveillance and family screening.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.